Prognosis impact of posttreatment pelvic MRI in patients treated for stage IB2-IIB cervical cancer with chemoradiation therapy.

Date publication

octobre 2020

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GRAESSLIN Olivier

Tous les auteurs :
Moussilmani T, Knight S, Mancini J, Touboul C, Rodriguez F, Bolze PA, Bendifallah S, Ballester M, Collinet P, Kerbage Y, Ouldamer L, Atrous G, Lavoué V, Dion L, Dabi Y, Raimond E, Graesslin O, Huchon C, Mimouni M, Bricou A, Golfier F, Carcopino X

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33160780

Résumé

To evaluate the performances of systematic posttreatment pelvic magnetic resonance imaging (PPMRI) in predicting prognosis of patients treated with chemoradiation therapy (CRT) for locally advanced cervical cancer (LACC).

Mots clés

Cervical cancer, Chemoradiation, Pelvic MRI, Prognosis, Recurrence, Survival

Référence

Eur J Surg Oncol. 2020 Oct 13;: